INSERTING and REPLACING Takeda Provides Further Information about its New Business Venture with Teva

OSAKA, Japan & Jerusalem–(BUSINESS WIRE)–Insert after 1st sentence in last bullet of release: The new business venture will be instantly accretive to Teva’s non GAAP EPS in 2016 and beyond. The corrected release reads:  TAKEDA PROVIDES FURTHER INFORMATION ABOUT ITS NEW BUSINESS VENTURE WITH TEVA Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Takeda Pharmaceutical Company Limited (TSE: 4502) today made the below follow-up announcement regarding the overview of their new business
Source: BusinessWire-Primary
{inline_image}